Paul Callahan

President at CDT Pharma Strategies

Paul Callahan is the President and Founder of CDT Pharma Strategies; CDT represents one of the only remaining independent strategy consulting firms in the USA. Paul brings over 33 years of diverse leadership across multiple manufacturers and consulting firms. His real-world channel insights and strategies benefit Biotech Organizations across Therapeutic Areas including Cell & Gene, Rare, Oncology, Rheumatology, Gastroenterology, Neurology, Cardiovascular, Infertility, Dermatology and Anti-infective agents.

Paul’s proven subject matter expertise spans the full range of commercial operations with a focus on channel, distribution and trade market access strategies and implementation support. Specifically for current clients he provides not only channel and distribution strategies, but also currently operates as the market access lead for trade and distribution for emerging and start up manufacturers bringing their first product to market.

Paul earned his MBA from The Pennsylvania State University and a BA in Accounting from Holy Family University.